| Net Income Per Share A reconciliation of net income available to common stockholders and the number of shares in the calculation of basic and diluted earnings income per share was calculated as follows: | | | | | | | | | | | | | | | | | For the Three Months Ended March 31, | | | (Dollars in thousands, except for share and per share amounts) | 2026 | | 2025 | | | | | | Net income attributable to Privia Health Group, Inc. common stockholders | $ | 3,064 | | | $ | 4,220 | | | | | | | Weighted average common shares outstanding - basic | 124,152,526 | | | 120,623,670 | | | | | | | Weighted average common share outstanding - diluted | 130,878,939 | | | 127,752,527 | | | | | | | Earnings per share attributable to Privia Health Group, Inc. common stockholders – basic | $ | 0.02 | | | $ | 0.03 | | | | | | | Earnings per share attributable to Privia Health Group, Inc. common stockholders – diluted | $ | 0.02 | | | $ | 0.03 | | | | | |
Below are the weighted-average diluted shares outstanding that were excluded from the computation of diluted loss per share attributable to common stockholders for the period presented because they were anti-dilutive: | | | | | | | | | | | | | Three Months Ended March 31, | | 2026 | | 2025 | | Weighted-average antidilutive shares outstanding | 4,158,027 | | | 3,993,189 | |
|